559-568
Original Article
Open AccessAnti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin
Rundi Ma, Gang Song, Wenbing You, Lijian Yu and Weiming Su, et al.
569-576
Original Article
c-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells
Eiko Takada, Kikumi Hata and Junichiro Mizuguchi
577-584
Original Article
Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines
Noriaki Kitada, Kohji Takara, Tetsuya Minegaki, Chihiro Itoh and Masayuki Tsujimoto, et al.
585-594
Original Article
Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines
Songyot Anuchapreeda, Singkome Tima, Chadarat Duangrat and Pornngarm Limtrakul
595-604
Original Article
Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP)
Saška Marczi, Ljubica Glavaš-Obrovac, Tatjana Belovari, Ranko Stojković and Siniša Ivanković, et al.
605-620
Original Article
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice
Laura K. Zerbe, Lori D. Dwyer-Nield, Jason M. Fritz, Elizabeth F. Redente and Robert J. Shroyer, et al.
621-629
Original Article
Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft
M. Bigioni, A. Benzo, C. Irrissuto, G. Lopez and B. Curatella, et al.
631-646
Original Article
A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors
Laura Q. M. Chow, S. Gail Eckhardt, Cindy L. O’Bryant, Mary Kay Schultz and Mark Morrow, et al.
647-653
Original Article
Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas
T. Clark Gamblin, Merrill J. Egorin, Eleanor G. Zuhowski, Theodore F. Lagattuta and Laurie L. Herscher, et al.
655-665
Original Article
Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide
Franca Formelli, Elena Cavadini, Roberto Luksch, Alberto Garaventa and Maria Grazia Villani, et al.
667-672
Original Article
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel
Rosalba Torrisi, Alessandra Balduzzi, Raffaella Ghisini, Andrea Rocca and Luca Bottiglieri, et al.
673-678
Original Article
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma
M. Reni, R. Berardi, A. Mambrini, L. Pasetto and S. Cereda, et al.
679-683
Original Article
Pharmacokinetics of heated intraperitoneal oxaliplatin
G. Ferron, S. Dattez, L. Gladieff, J.-P. Delord and S. Pierre, et al.
685-688
Original Article
Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients
Jens Atzpodien, Kerstin Terfloth, Michael Fluck and Martina Reitz
689-697
Original Article
BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity
Hyo Jin Kang, Hee Jeong Kim, Sang Hoon Kwon, Brian DongHoon Kang and Thomas E. Eling, et al.
699-706
Original Article
Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy
Danny Rogers, Karen D. Nylander, Zhiping Mi, Tong Hu and Nina F. Schor
707-716
Original Article
Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4
Z.-Y. Zhang, B. M. King, R. D. Pelletier and Y. N. Wong
717-725
Clinical Trial Report
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation
Alessandra Fabi, Giulio Metro, Paola Papaldo, Marcella Mottolese and Elisa Melucci, et al.
727-733
Clinical Trial Report
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
William Schelman, Sherry Morgan-Meadows, Howard Bailey, Kyle Holen and James P. Thomas, et al.
735-739
Short Communication
Imatinib inhibition of fludarabine uptake in T-lymphocytes
Erica L. Woodahl, Joanne Wang, Shelly Heimfeld, Aaron G. Ren and Jeannine S. McCune
741-743
Short Communcation
Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient
Massimo Gentile, Eugenio Lucia, Caterina Iorio, Ernesto Vigna and Carla Mazzone, et al.